Abstract
Background/objectives
The relationship between gut microbiota and changes in body mass index (BMI) or pediatric overweight in early life remains unclear, and information regarding the preterm population is scarce. This study aimed to investigate how the gut microbiota at 3.5 years of age is associated with (1) later BMI at 5 years, and (2) BMI z-score variations between 2 and 5 years in children from two French nationwide birth cohorts.
Subjects/methods
Bacterial 16S rRNA gene sequencing was performed to profile the gut microbiota at 3.5 years of age in preterm children (n = 143, EPIPAGE 2 cohort) and late preterm/full-term children (n = 369, ELFE cohort). The predicted abundances of metabolic functions were computed using PICRUSt2. Anthropometric measurements were collected at 2 and 5 years of age during medical examinations or retrieved from children’s health records. Statistical analyses included multivariable linear and logistic regressions, random forest variable selection, and MiRKAT.
Results
The Firmicutes to Bacteroidetes (F/B) ratio at 3.5 years was positively associated with the BMI z-score at 5 years. Several genera were positively ([Eubacterium] hallii group, Fusicatenibacter, and [Eubacterium] ventriosum group) or negatively (Eggerthella, Colidextribacter, and Ruminococcaceae CAG-352) associated with the BMI z-scores at 5 years. Some genera were also associated with variations in the BMI z-scores between 2 and 5 years of age. Predicted metabolic functions, including steroid hormone biosynthesis, biotin metabolism, glycosaminoglycan degradation, and amino sugar and nucleotide sugar metabolism, were associated with lower BMI z-scores at 5 years. The unsaturated fatty acids biosynthesis pathway was associated with higher BMI z-scores.
Conclusions
These findings indicate that the gut microbiota at 3.5 years is associated with later BMI during childhood, independent of preterm or term birth, suggesting that changes in the gut microbiota that may predispose to adult obesity begin in early childhood.
Similar content being viewed by others
Data availability
The data from the ELFE and EPIPAGE 2 cohorts cannot be made publicly available for ethical reasons. They are available upon reasonable request from the authors upon reasonable request and under data-security conditions. The 16S rRNA gene reads are publicly available from the National Center for Biotechnology Information Sequence Read Archive (SRA) under the Bioproject accession number PRJNA907285.
References
Di Cesare M, Sorić M, Bovet P, Miranda JJ, Bhutta Z, Stevens GA, et al. The epidemiological burden of obesity in childhood: a worldwide epidemic requiring urgent action. BMC Med. 2019;17:212.
World Health Organization. Obesity and overweight. World Health Organization. Published 2021 Accessed January 11, 2023 [Internet]. 2021 [cited 2023 Jan 11]. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
Kadouh HC, Acosta A. Current paradigms in the etiology of obesity. Tech Gastrointest Endosc. 2017;19:2–11.
Suzuki K. The develo** world of DOHaD. J Dev Orig Health Dis. 2018;9:266–9.
Butel MJ, Waligora-Dupriet AJ, Wydau-Dematteis S. The develo** gut microbiota and its consequences for health. J Dev Orig Health Dis. 2018;9:590–7.
Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci. 2005;102:11070–5.
Petraroli M, Castellone E, Patianna V. Esposito S. gut microbiota and obesity in adults and children: the state of the art. Front Pediatr. 2021;9:657020.
Cho KY. Association of gut microbiota with obesity in children and adolescents. Clin Exp Pediatr [Internet]. 2022 Nov 16 [cited 2023 Jan 3]; Available from: http://e-cep.org/journal/view.php?doi=10.3345/cep.2021.01837
Pinart M, Dötsch A, Schlicht K, Laudes M, Bouwman J, Forslund SK, et al. Gut microbiome composition in obese and non-obese persons: a systematic review and meta-analysis. Nutrients. 2021;14:12.
Dalby MJ. Questioning the foundations of the gut microbiota and obesity. Philos Trans R Soc B Biol Sci. 2023;378:20220221.
Sanchez M, Panahi S, Tremblay A. Childhood obesity: a role for gut microbiota? Int J Environ Res Public Health. 2014;12:162–75.
Cuevillas B, Milagro FI, Tur JA, Gil‐Campos M, Miguel‐Etayo P, Martínez JA, et al. Fecal microbiota relationships with childhood obesity: A sco** comprehensive review. Obes Rev [Internet]. 2022 Jan [cited 2022 Jul 12];23(S1). Available from: https://onlinelibrary.wiley.com/doi/10.1111/obr.13394
Houtman TA, Eckermann HA, Smidt H, de Weerth C. Gut microbiota and BMI throughout childhood: the role of firmicutes, bacteroidetes, and short-chain fatty acid producers. Sci Rep. 2022;12:3140.
Scheepers LEJM, Penders J, Mbakwa CA, Thijs C, Mommers M, Arts ICW. The intestinal microbiota composition and weight development in children: the KOALA birth cohort study. Int J Obes. 2015;39:16–25.
Stanislawski MA, Dabelea D, Wagner BD, Iszatt N, Dahl C, Sontag MK. et al. Gut microbiota in the first 2 years of life and the association with body mass index at age 12 in a Norwegian birth cohort. MBio. 2018;9:10–128.
Vael C, Verhulst SL, Nelen V, Goossens H, Desager KN. Intestinal microflora and body mass index during the first three years of life: an observational study. Gut Pathog. 2011;3:8.
Bergström A, Skov TH, Bahl MI, Roager HM, Christensen LB, Ejlerskov KT, et al. Establishment of intestinal microbiota during early life: a longitudinal, explorative study of a large cohort of Danish infants. Appl Environ Microbiol. 2014;80:2889–900.
Qiu J, Zhou C, **ang S, Dong J, Zhu Q, Yin J, et al. Association between trajectory patterns of body mass index change up to 10 months and early gut microbiota in preterm infants. Front Microbiol. 2022;13:828275.
Tadros JS, Llerena A, Sarkar A, Johnson R, Miller EM, Gray HL, et al. Postnatal growth and gut microbiota development influenced early childhood growth in preterm infants. Front Pediatr. 2022;10:850629.
Gnawali A. Prematurity and the Risk of Development of Childhood Obesity: Piecing Together the Pathophysiological Puzzle. A Literature Review. Cureus [Internet]. 2021 Dec [cited 2023 Jan 30]; Available from: https://www.cureus.com/articles/77978-prematurity-and-the-risk-of-development-of-childhood-obesity-piecing-together-the-pathophysiological-puzzle-a-literature-review
Ou-Yang MC, Sun Y, Liebowitz M, Chen CC, Fang ML, Dai W, et al. Accelerated weight gain, prematurity, and the risk of childhood obesity: a meta-analysis and systematic review. Salinas Miranda A, editor. PLoS One. 2020;15:e0232238.
Lorthe E, Benhammou V, Marchand-Martin L, Pierrat V, Lebeaux C, Durox M, et al. Cohort Profile: The Etude Epidémiologique sur les Petits Ages Gestationnels-2 (EPIPAGE-2) preterm birth cohort. Int J Epidemiol. 2021;50:1428–9m.
Charles MA, Thierry X, Lanoe JL, Bois C, Dufourg MN, Popa R, et al. Cohort profile: the French national cohort of children (ELFE): birth to 5 years. Int J Epidemiol. 2020;49:368–9j.
de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ. 2007;85:660–7.
Toubon G, Butel MJ, Rozé JC, Nicolis I, Delannoy J, Zaros C, et al. Early Life Factors Influencing Children Gut Microbiota at 3.5 Years from two French birth cohorts. Microorganisms. 2023;11:1390.
Dore J, Ehrlich SD, Levenez F, Pelletier E, Alberti A, Bertrand L, et al. HMS_SOP_07_V1: standard operating procedure for fecal samples DNA extraction, protocol H. International Human Microbiome Standards. [Internet]. 2015. Available from: http://www.microbiome-standards.org
Douglas GM, Maffei VJ, Zaneveld JR, Yurgel SN, Brown JR, Taylor CM, et al. PICRUSt2 for prediction of metagenome functions. Nat Biotechnol. 2020;38:685–8.
Zhao N, Chen J, Carroll IM, Ringel-Kulka T, Epstein MP, Zhou H, et al. Testing in microbiome-profiling studies with MiRKAT, the microbiome regression-based Kernel association test. Am J Hum Genet. 2015;96:797–807.
Genuer R, Poggi JM, Tuleau-Malot C. VSURF: an R package for variable selection using random forests. R J. 2015;7:19.
Aria M, Cuccurullo C, Gnasso A. A comparison among interpretative proposals for random forests. Mach Learn Appl. 2021;6:100094.
Stekhoven DJ, Buhlmann P. MissForest–non-parametric missing value imputation for mixed-type data. Bioinformatics. 2012;28:112–8.
Xu P, Li M, Zhang J, Zhang T. Correlation of intestinal microbiota with overweight and obesity in Kazakh school children. BMC Microbiol. 2012;12:283.
Bervoets L, Van Hoorenbeeck K, Kortleven I, Van Noten C, Hens N, Vael C, et al. Differences in gut microbiota composition between obese and lean children: a cross-sectional study. Gut Pathog. 2013;5:10.
Indiani CM, dos SP, Rizzardi KF, Castelo PM, Ferraz LFC, Darrieux M, et al. Childhood obesity and firmicutes/bacteroidetes ratio in the gut microbiota: a systematic review. Child Obes. 2018;14:501–9.
Shin S, Cho KY. Altered gut microbiota and shift in Bacteroidetes between young obese and normal-weight Korean children: a cross-sectional observational study. BioMed Res Int. 2020;2020:1–19.
Reffien MAM, Azit NA, Pakhrurdin NAM, Hassan R, Ahmad N, Nawi AM. The effects of gut microbiota on childhood obesity: a systematic review and meta-analysis. Hong Kong J Paediatr Res. 2019;2:52–62.
Stojanov S, Berlec A, Štrukelj B. The influence of probiotics on the firmicutes/bacteroidetes ratio in the treatment of obesity and inflammatory bowel disease. Microorganisms. 2020;8:1715.
de la Cuesta-Zuluaga J, Mueller N, Álvarez-Quintero R, Velásquez-Mejía E, Sierra J, Corrales-Agudelo V, et al. Higher fecal short-chain fatty acid levels are associated with gut microbiome dysbiosis, obesity, hypertension, and cardiometabolic disease risk factors. Nutrients. 2018;11:51.
Kumari M, Kozyrskyj AL. Gut microbial metabolism defines host metabolism: an emerging perspective in obesity and allergic inflammation: Gut metabolites in obesity and allergy. Obes Rev. 2017;18:18–31.
Sanmiguel C, Gupta A, Mayer EA. Gut microbiome and obesity: a plausible explanation for obesity. Curr Obes Rep. 2015;4:250–61.
Murugesan S, Nirmalkar K, Hoyo-Vadillo C, García-Espitia M, Ramírez-Sánchez D, García-Mena J. Gut microbiome production of short-chain fatty acids and obesity in children. Eur J Clin Microbiol Infect Dis. 2018;37:621–5.
Cho KY. Lifestyle modifications result in alterations in the gut microbiota in obese children. BMC Microbiol. 2021;21:10.
Leong C, Haszard JJ, Heath ALM, Tannock GW, Lawley B, Cameron SL, et al. Using compositional principal component analysis to describe children’s gut microbiota in relation to diet and body composition. Am J Clin Nutr. 2020;111:70–8.
Vazquez‐Moreno M, Perez‐Herrera A, Locia‐Morales D, Dizzel S, Meyre D, Stearns JC, et al. Association of gut microbiome with fasting triglycerides, fasting insulin and obesity status in Mexican children. Pediatr Obes [Internet]. 2021 May [cited 2023 Jan 5];16. Available from: https://onlinelibrary.wiley.com/doi/10.1111/ijpo.12748
Kasai C, Sugimoto K, Moritani I, Tanaka J, Oya Y, Inoue H, et al. Comparison of the gut microbiota composition between obese and non-obese individuals in a Japanese population, as analyzed by terminal restriction fragment length polymorphism and next-generation sequencing. BMC Gastroenterol. 2015;15:100.
Tims S, Derom C, Jonkers DM, Vlietinck R, Saris WH, Kleerebezem M, et al. Microbiota conservation and BMI signatures in adult monozygotic twins. ISME J. 2013;7:707–17.
Vacca M, Celano G, Calabrese FM, Portincasa P, Gobbetti M, De Angelis M. The controversial role of human gut lachnospiraceae. Microorganisms. 2020;8:573.
Tun HM, Bridgman SL, Chari R, Field CJ, Guttman DS, Becker AB, et al. Roles of birth mode and infant gut microbiota in intergenerational transmission of overweight and obesity from mother to offspring. JAMA Pediatr. 2018;172:368.
Abuqwider JN, Mauriello G, Altamimi M. Akkermansia muciniphila, a new generation of beneficial microbiota in modulating obesity: a systematic review. Microorganisms. 2021;9:1098.
Karlsson CLJ, Önnerfält J, Xu J, Molin G, Ahrné S, Thorngren-Jerneck K. The microbiota of the gut in preschool children with normal and excessive body weight. Obesity. 2012;20:2257–61.
Machate DJ, Figueiredo PS, Marcelino G, Guimarães R, de CA, Hiane PA, et al. Fatty acid diets: regulation of gut microbiota composition and obesity and its related metabolic dysbiosis. Int J Mol Sci. 2020;21:4093.
Lyte JM, Gabler NK, Hollis JH. Postprandial serum endotoxin in healthy humans is modulated by dietary fat in a randomized, controlled, cross-over study. Lipids Health Dis. 2016;15:186.
de Lorgeril M, Salen P. New insights into the health effects of dietary saturated and omega-6 and omega-3 polyunsaturated fatty acids. BMC Med. 2012;10:50.
Liberali R, Kupek E, de Assis MAA. Dietary patterns and childhood obesity risk: a systematic review. Child Obes. 2020;16:70–85.
Del Chierico F, Abbatini F, Russo A, Quagliariello A, Reddel S, Capoccia D, et al. Gut microbiota markers in obese adolescent and adult patients: age-dependent differential patterns. Front Microbiol. 2018;9:1210.
Hou YP, He QQ, Ouyang HM, Peng HS, Wang Q, Li J, et al. Human gut microbiota associated with obesity in chinese children and adolescents. BioMed Res Int. 2017;2017:1–8.
Mayes JS, Watson GH. Direct effects of sex steroid hormones on adipose tissues and obesity. Obes Rev. 2004;5:197–216.
Huskisson E, Maggini S, Ruf M. The role of vitamins and minerals in energy metabolism and well-being. J Int Med Res. 2007;35:277–89.
Sanz Y, Olivares M. Tiny contributors to severe obesity inside the gut. Gut. 2022;71:2376–8.
Belda E, Voland L, Tremaroli V, Falony G, Adriouch S, Assmann KE, et al. Impairment of gut microbial biotin metabolism and host biotin status in severe obesity: effect of biotin and prebiotic supplementation on improved metabolism. Gut. 2022;71:2463–80.
Chávez-Carbajal A, Nirmalkar K, Pérez-Lizaur A, Hernández-Quiroz F, Ramírez-del-Alto S, García-Mena J, et al. Gut microbiota and predicted metabolic pathways in a sample of Mexican women affected by obesity and obesity plus metabolic syndrome. Int J Mol Sci. 2019;20:438.
Funding
The ELFE cohort is a joint project between the French Institute for Demographic Studies (INED) and the National Institute of Health and Medical Research (INSERM), in partnership with the French blood transfusion service (Etablissement Français du Sang, EFS), Santé publique France, the National Institute for Statistics and Economic Studies (INSEE), the Direction Générale de la Santé (DGS, part of the Ministry of Health and Social Affairs), the Direction Générale de la Prévention des Risques (DGPR, Ministry for the Environment), the Direction de la Recherche, des Etudes, de l’Evaluation et des Statistiques (DREES, Ministry of Health and Social Affairs), the Département des Etudes, de la Prospective et des Statistiques (DEPS, Ministry of Culture), and the Caisse Nationale des Allocations Familiales (CNAF), with the support of the Ministry of Higher Education and Research and the Institut national de la Jeunesse et de l’Education Populaire (INJEP). The ELFE cohort receives a government grant managed by the National Research Agency under the “Investissements d’avenir” program (ANR-11-EQPX-0038, ANR-19-COHO-0001). The EPIPAGE 2 cohort was funded by the French Institute of Public Health and its partners: the French Health Ministry, The National Institute of Health and Medical Research, the National Institute of Cancer, and the National Solidarity Fund for Autonomy, the National Research Agency under the French Equipex program of “Investissements d’avenir” (ANR-11-EQPX-0038, ANR-19-COHO-0001), and the PremUp foundation. The EPIFLORE ancillary study has been funded by the French National Agency for Research (ANR-12-BSV3–0025), and the Nestec Research Center (Vers-chez-les-Blanc, Switzerland) for the constitution of the collection of stools. The 16S rRNA sequencing was funded by the Biostime Institute for Nutrition and Care-Geneva (BINC-Geneva).
Author information
Authors and Affiliations
Contributions
J-CR, M-JB, M-AC, P-YA, and JA were responsible for data collection. GT, M-JB, M-AC, and JA designed the research. GT and JD analyzed the data. GT drafted the manuscript and J-CR, M-JB, M-AC, P-YA, JA, and JD contributed to writing the manuscript. All authors have read and agreed to the published version of the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Toubon, G., Butel, MJ., Rozé, JC. et al. Association between gut microbiota at 3.5 years of age and body mass index at 5 years: results from two French nationwide birth cohorts. Int J Obes 48, 503–511 (2024). https://doi.org/10.1038/s41366-023-01442-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41366-023-01442-x
- Springer Nature Limited